[Keratoacanthoma: therapeutic indications].
Heid
E
E
Clinique Dermatologique, Hôpital Civil, Strasbourg.
D000970:Antineoplastic Agents / Q000008:administration & dosage; D003131:Combined Modality Therapy; D006801:Humans; D015552:Injections, Intralesional; D007636:Keratoacanthoma / Q000628:therapy*; D012176:Retinoids / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents; D012176:Retinoids
Kératoacanthome (KA): indications thérapeutiques.